# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001159036-24-000024
Filing Date
2024-03-15
Accepted
2024-03-15 16:06:04
Documents
27
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | halo-20240313.htm iXBRL | DEF 14A | 941767
6 | GRAPHIC | halo-20240313_g1.jpg | GRAPHIC | 38428
7 | GRAPHIC | halo-20240313_g10.jpg | GRAPHIC | 27272
8 | GRAPHIC | halo-20240313_g11.jpg | GRAPHIC | 166532
9 | GRAPHIC | halo-20240313_g12.jpg | GRAPHIC | 137763
10 | GRAPHIC | halo-20240313_g2.jpg | GRAPHIC | 31598
11 | GRAPHIC | halo-20240313_g3.jpg | GRAPHIC | 16244
12 | GRAPHIC | halo-20240313_g4.jpg | GRAPHIC | 14700
13 | GRAPHIC | halo-20240313_g5.jpg | GRAPHIC | 36365
14 | GRAPHIC | halo-20240313_g6.jpg | GRAPHIC | 36425
15 | GRAPHIC | halo-20240313_g7.jpg | GRAPHIC | 52580
16 | GRAPHIC | halo-20240313_g8.jpg | GRAPHIC | 30016
17 | GRAPHIC | halo-20240313_g9.jpg | GRAPHIC | 28116
| Complete submission text file | 0001159036-24-000024.txt |  | 2943643

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | halo-20240313.xsd | EX-101.SCH | 3670
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | halo-20240313_def.xml | EX-101.DEF | 4896
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | halo-20240313_lab.xml | EX-101.LAB | 6700
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | halo-20240313_pre.xml | EX-101.PRE | 3882
28 | EXTRACTED XBRL INSTANCE DOCUMENT | halo-20240313_htm.xml | XML | 82033

Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32335 | Film No.: 24754726
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)